The company said its Q1 2025 revenue was $2.25 billion, up 19% from $1.89 billion in Q1 2024. It also said worldwide da Vinci procedures grew about 17% over Q1 2024.

1. 01

   The company said its Q1 2025 revenue was $2.25 billion, up 19% from $1.89 billion in Q1 2024. It also said worldwide da Vinci procedures grew about 17% over Q1 2024.

2. 02

   The company said it placed 367 da Vinci surgical systems in Q1 2025, of which 147 were da Vinci 5. In Q1 2024, it placed 8 of 313 systems. The da Vinci installed base was 10,189 systems as of March 31, 2025.

3. 03

   Intuitive Surgical said its GAAP net income attributable to Intuitive for Q1 2025 was $698 million, or $1.92 per diluted share, and that this included excess tax benefits related to share-based compensation of $145 million.

4. 04

   The company expects non-GAAP gross profit margin for 2025 to be between 65% and 66.5% of revenue, and said the range includes an estimated tariff impact of 1.7% of revenue, plus or minus 30 basis points. Non-GAAP gross profit margin for 2024 was 69.1%.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.